within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BB01_AntiDRhImmunoglobulin;

model AntiDRhImmunoglobulin
  extends Pharmacolibrary.Drugs.ATC.J.J06BB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J06BB01</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Anti-D (Rh) immunoglobulin is a human IgG antibody preparation used for prevention of RhD alloimmunization, primarily in Rh-negative pregnant women to prevent hemolytic disease of the fetus and newborn. It is also used after incompatible transfusions or other situations with potential Rh antigen exposure. The drug is approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult healthy volunteers after intramuscular injection of anti-D immunoglobulin.</p><h4>References</h4><ol><li><p>Jilma-Stohlawetz, P, et al., &amp; Jilma, B (2005). Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK. <i>Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis</i> 33(2) 135–140. DOI:<a href=\"https://doi.org/10.1016/j.transci.2005.02.006\">10.1016/j.transci.2005.02.006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16112906/\">https://pubmed.ncbi.nlm.nih.gov/16112906</a></p></li><li><p>Bichler, J, et al., &amp; Andresen, I (2003). Pharmacokinetics of anti-D IgG in pregnant RhD-negative women. <i>BJOG : an international journal of obstetrics and gynaecology</i> 110(1) 39–45. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12504934/\">https://pubmed.ncbi.nlm.nih.gov/12504934</a></p></li><li><p>Tiblad, E, et al., &amp; Westgren, M (2012). Pharmacokinetics of 250 μg anti-D IgG in the third trimester of pregnancy: an observational study. <i>Acta obstetricia et gynecologica Scandinavica</i> 91(5) 587–592. DOI:<a href=\"https://doi.org/10.1111/j.1600-0412.2012.01377.x\">10.1111/j.1600-0412.2012.01377.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22352370/\">https://pubmed.ncbi.nlm.nih.gov/22352370</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AntiDRhImmunoglobulin;
